Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2779498-79-0
2. Vv116 Hydrobromide
3. P4l9q2t94l
4. Chembl5314972
5. Deuremidevir Hydrobromide [who-dd]
6. Ex-a5453
7. Hy-145119as
8. Ms-30448
9. Jt001; Gs-621763-d1
10. Cs-0498811
11. [(2r,3r,4r,5r)-5-(4-amino-5-deuteriopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-bis(2-methylpropanoyloxy)oxolan-2-yl]methyl 2-methylpropanoate;hydrobromide
12. D-altrononitrile, 2-c-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl-5-d)-2,5-anhydro-, 3,4,6-tris(2-methylpropanoate), Hydrobromide (1:1)
| Molecular Weight | 583.4 g/mol |
|---|---|
| Molecular Formula | C24H32BrN5O7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 11 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 168 |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 887 |
| Isotope Atom Count | 1 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
26
PharmaCompass offers a list of Deuremidevir hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Deuremidevir hydrobromide manufacturer or Deuremidevir hydrobromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deuremidevir hydrobromide manufacturer or Deuremidevir hydrobromide supplier.
A Deuremidevir hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deuremidevir hydrobromide, including repackagers and relabelers. The FDA regulates Deuremidevir hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deuremidevir hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Deuremidevir hydrobromide supplier is an individual or a company that provides Deuremidevir hydrobromide active pharmaceutical ingredient (API) or Deuremidevir hydrobromide finished formulations upon request. The Deuremidevir hydrobromide suppliers may include Deuremidevir hydrobromide API manufacturers, exporters, distributors and traders.
Deuremidevir hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Deuremidevir hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Deuremidevir hydrobromide GMP manufacturer or Deuremidevir hydrobromide GMP API supplier for your needs.
A Deuremidevir hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Deuremidevir hydrobromide's compliance with Deuremidevir hydrobromide specifications and serves as a tool for batch-level quality control.
Deuremidevir hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Deuremidevir hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Deuremidevir hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Deuremidevir hydrobromide EP), Deuremidevir hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Deuremidevir hydrobromide USP).
